{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:38:21Z","timestamp":1794883101317,"version":"4.9.1"},"reference-count":46,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19AIML34980000"],"award-info":[{"award-number":["19AIML34980000"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["U01 125215"],"award-info":[{"award-number":["U01 125215"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-HL0007633"],"award-info":[{"award-number":["T32-HL0007633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2024,5,20]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Despite shared features with pulmonary arterial hypertension, acute vasoreactivity in pulmonary hypertension with interstitial lung disease (PH-ILD) is not well characterised, including its potential ability to predict therapeutic outcomes. We sought to determine whether acute vasoreactivity in PH-ILD to oxygen (O<jats:sub>2<\/jats:sub>) and inhaled nitric oxide (iNO) predicts inhaled treprostinil (iTre) outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>In this retrospective cohort analysis, we identified treatment-naive PH-ILD patients with vasoreactivity testing using O<jats:sub>2<\/jats:sub>and O<jats:sub>2<\/jats:sub>+iNO. 6-month iTre outcome was assessed. \u201ciTre improvement\u201d required fulfilment of criteria on objective assessment without clinical worsening. \u201ciTre failure\u201d was defined by lack of objective improvement or a clinical worsening event.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 75 PH-ILD patients, mean pulmonary arterial pressure (mPAP) decreased by \u22123\u2005mmHg (\u221212.6%) and pulmonary vascular resistance (PVR) by \u22121.3\u2005WU (\u221223.7%) with O<jats:sub>2<\/jats:sub>+iNO. With O<jats:sub>2<\/jats:sub>+iNO, mPAP decreased \u226510\u2005mmHg to &lt;40\u2005mmHg in four patients (5.3%) and 23 (30.7%) had \u226520% reduction in mPAP and PVR. Among 33 iTre-treated patients, there were 13 improvements and 20 failures. The microvascular response, measured by distensibility, to O<jats:sub>2<\/jats:sub>alone<jats:italic>versus<\/jats:italic>O<jats:sub>2<\/jats:sub>+iNO correlated with 6-month iTre outcome. Patients with 6-month iTre improvement had large relative distensibility increases with O<jats:sub>2<\/jats:sub>+iNO (<jats:italic>versus<\/jats:italic>failure, 76.0%<jats:italic>versus<\/jats:italic>15.3%, p=0.004). Conversely, iTre failure was associated with increased distensibility with O<jats:sub>2<\/jats:sub>alone (<jats:italic>versus<\/jats:italic>improvement, 26.8%<jats:italic>versus<\/jats:italic>\u22123.9%, p=0.045).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In PH-ILD, the microvascular response to O<jats:sub>2<\/jats:sub><jats:italic>versus<\/jats:italic>O<jats:sub>2<\/jats:sub>+iNO testing was associated with 6-month iTre outcome, likely reflecting the differential contributions of hypoxic vasoconstriction and remodelling. Acute vasoreactivity may inform therapeutic decision-making in PH-ILD.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00201-2024","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T15:45:14Z","timestamp":1716997514000},"page":"00201-2024","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Vasoreactivity and inhaled treprostinil response in interstitial lung disease pulmonary hypertension"],"prefix":"10.1183","volume":"10","author":[{"given":"Eileen M.","family":"Harder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod N.","family":"Rahaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Systrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Washko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-0361","authenticated-orcid":false,"given":"Aaron B.","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"key":"2025011303501467000_10.6.00201-2024.1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7326\/M14-1402","article-title":"Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension","volume":"162","author":"Langleben","year":"2015","journal-title":"Ann Intern Med"},{"key":"2025011303501467000_10.6.00201-2024.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"2025011303501467000_10.6.00201-2024.3","doi-asserted-by":"crossref","first-page":"e12181","DOI":"10.1002\/pul2.12181","article-title":"Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study","volume":"13","author":"Frantz","year":"2023","journal-title":"Pulm Circ"},{"key":"2025011303501467000_10.6.00201-2024.4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.14797\/AFUI4711","article-title":"Under pressure: right heart catheterization and provocative testing for diagnosing pulmonary hypertension","volume":"17","author":"Tea","year":"2021","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2025011303501467000_10.6.00201-2024.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330403"},{"key":"2025011303501467000_10.6.00201-2024.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000532"},{"key":"2025011303501467000_10.6.00201-2024.7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.chest.2019.04.111","article-title":"Pulmonary vascular distensibility and early pulmonary vascular remodeling in pulmonary hypertension","volume":"156","author":"Singh","year":"2019","journal-title":"Chest"},{"key":"2025011303501467000_10.6.00201-2024.8","doi-asserted-by":"crossref","first-page":"2045894019862435","DOI":"10.1177\/2045894019862435","article-title":"Dynamic right ventricular-pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension","volume":"9","author":"Singh","year":"2019","journal-title":"Pulm Circ"},{"key":"2025011303501467000_10.6.00201-2024.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.787101"},{"key":"2025011303501467000_10.6.00201-2024.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008470"},{"key":"2025011303501467000_10.6.00201-2024.11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.healun.2021.02.006","article-title":"Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: a post hoc subgroup analysis of the RISE-IIP study","volume":"40","author":"Nathan","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2025011303501467000_10.6.00201-2024.12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study","volume":"7","author":"Nathan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2025011303501467000_10.6.00201-2024.13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00213911"},{"key":"2025011303501467000_10.6.00201-2024.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"2025011303501467000_10.6.00201-2024.15","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"2025011303501467000_10.6.00201-2024.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00021005"},{"key":"2025011303501467000_10.6.00201-2024.17","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1164\/rccm.202206-1041ST","article-title":"Syndrome of combined pulmonary fibrosis and emphysema: an official ATS\/ERS\/JRS\/ALAT research statement","volume":"206","author":"Cottin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2025011303501467000_10.6.00201-2024.18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006363"},{"key":"2025011303501467000_10.6.00201-2024.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00074312"},{"key":"2025011303501467000_10.6.00201-2024.20","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201509-599FR"},{"key":"2025011303501467000_10.6.00201-2024.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00741-2015"},{"key":"2025011303501467000_10.6.00201-2024.22","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2012.234310"},{"key":"2025011303501467000_10.6.00201-2024.23","doi-asserted-by":"crossref","first-page":"e12029","DOI":"10.1002\/pul2.12029","article-title":"Pulmonary vascular distensibility with passive leg raise is comparable to exercise and predictive of clinical outcomes in pulmonary hypertension","volume":"12","author":"Kozitza","year":"2022","journal-title":"Pulm Circ"},{"key":"2025011303501467000_10.6.00201-2024.24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1152\/jappl.1992.73.3.987","article-title":"A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves","volume":"73","author":"Linehan","year":"1992","journal-title":"J Appl Physiol (1985)"},{"key":"2025011303501467000_10.6.00201-2024.25","doi-asserted-by":"crossref","first-page":"e029667","DOI":"10.1161\/JAHA.123.029667","article-title":"iCPET calculator: a web-based application to standardize the calculation of alpha distensibility in patients with pulmonary arterial hypertension","volume":"12","author":"Elliott","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025011303501467000_10.6.00201-2024.26","doi-asserted-by":"crossref","first-page":"10.1161\/CIRCHEARTFAILURE.1115.00","DOI":"10.1161\/CIRCHEARTFAILURE.115.003011","article-title":"Pulmonary vascular distensibility predicts pulmonary hypertension severity, exercise capacity, and survival in heart failure","volume":"9","author":"Malhotra","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2025011303501467000_10.6.00201-2024.27","doi-asserted-by":"crossref","first-page":"2045894018787381","DOI":"10.1177\/2045894018787381","article-title":"Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility","volume":"8","author":"Wallace","year":"2018","journal-title":"Pulm Circ"},{"key":"2025011303501467000_10.6.00201-2024.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.07.004"},{"key":"2025011303501467000_10.6.00201-2024.29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00408-017-0081-7","article-title":"Inhaled treprostinil in pulmonary hypertension associated with lung disease","volume":"196","author":"Faria-Urbina","year":"2018","journal-title":"Lung"},{"key":"2025011303501467000_10.6.00201-2024.30","doi-asserted-by":"crossref","first-page":"2045894020962960","DOI":"10.1177\/2045894020962960","article-title":"Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension","volume":"10","author":"Sitbon","year":"2020","journal-title":"Pulm Circ"},{"key":"2025011303501467000_10.6.00201-2024.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.009690"},{"key":"2025011303501467000_10.6.00201-2024.32","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1002\/ehf2.13355","article-title":"A decrease in tricuspid regurgitation pressure gradient associates with favorable outcome in patients with heart failure","volume":"8","author":"Seko","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025011303501467000_10.6.00201-2024.33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13075-022-02835-5","article-title":"Defining minimal detectable difference in echocardiographic measures of right ventricular function in systemic sclerosis","volume":"24","author":"Mukherjee","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025011303501467000_10.6.00201-2024.34","doi-asserted-by":"crossref","first-page":"e26988","DOI":"10.1097\/MD.0000000000026988","article-title":"Estimation of pulmonary artery pressure with transesophageal echocardiography: an observer-blinded test accuracy study","volume":"100","author":"Mora","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"2025011303501467000_10.6.00201-2024.35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202208-1547OC"},{"key":"2025011303501467000_10.6.00201-2024.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2007.06.013"},{"key":"2025011303501467000_10.6.00201-2024.37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072013"},{"issue":"Suppl. 1","key":"2025011303501467000_10.6.00201-2024.38","first-page":"A10188","article-title":"Abstract 10188: sotatercept phase 3 program design and rationale: a novel treatment for pulmonary arterial hypertension","volume":"144","author":"Preston","year":"2021","journal-title":"Circulation"},{"key":"2025011303501467000_10.6.00201-2024.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413687"},{"key":"2025011303501467000_10.6.00201-2024.40","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1959"},{"key":"2025011303501467000_10.6.00201-2024.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.09.001"},{"key":"2025011303501467000_10.6.00201-2024.42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1152\/jappl.1994.77.1.51","article-title":"Sites of vasodilation by inhaled nitric oxide vs. sodium nitroprusside in endothelin-constricted isolated rat lungs","volume":"77","author":"Roos","year":"1994","journal-title":"J Appl Physiol (1985)"},{"key":"2025011303501467000_10.6.00201-2024.43","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00162.2004"},{"key":"2025011303501467000_10.6.00201-2024.44","doi-asserted-by":"crossref","first-page":"174484","DOI":"10.1016\/j.ejphar.2021.174484","article-title":"Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension","volume":"916","author":"Corboz","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"2025011303501467000_10.6.00201-2024.45","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00105110"},{"key":"2025011303501467000_10.6.00201-2024.46","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1164\/rccm.202312-2343LE","article-title":"Pulmonary hypertension in idiopathic interstitial pneumonia is associated with small vessel pruning","volume":"209","author":"Harder","year":"2024","journal-title":"Am J Respir Crit Care Med"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00201-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:37:39Z","timestamp":1740375459000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00201-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,2]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1183\/23120541.00201-2024"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00201-2024","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1183\/23120541.00201-2024.supp1","asserted-by":"subject"}]},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,29]]}}}